Electra Therapeutics, Inc. ($ETRA)
Filing Information
| Accession Number | 0000947871-26-000881 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 23, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
12,437,007
Total Value
$19,999,995.00
P&L
-15.5% ($3,106,665.89)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 21, 2026 | Conversion | 2,002,310 | โ | โ | 2,002,310 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 21, 2026 | Conversion | 1,087,934 | โ | โ | 3,090,244 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 21, 2026 | Conversion | 1,703,314 | โ | โ | 4,793,558 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 21, 2026 | Purchase | 333,333 | $15.00 | $4,999,995.00 | 5,126,891 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 21, 2026 | Conversion | 758,279 | โ | โ | 758,279 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 21, 2026 | Purchase | 1,000,000 | $15.00 | $15,000,000.00 | 1,758,279 | Indirect | See footnotes | View Details | |
Director | Series A Convertible Preferred Stock | Derivative | Sep 21, 2026 | Conversion | 2,002,310 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Series B Convertible Preferred Stock | Derivative | Sep 21, 2026 | Conversion | 1,087,934 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Series C Convertible Preferred Stock | Derivative | Sep 21, 2026 | Conversion | 1,703,314 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Series C Convertible Preferred Stock | Derivative | Sep 21, 2026 | Conversion | 758,279 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details |